Blood marker may flag dangerous preeclampsia early
NCT ID NCT06413576
First seen Apr 11, 2026 · Last updated Jun 19, 2026 · Updated 6 times
Summary
This study looked at 70 pregnant women with preeclampsia to see if higher homocysteine levels in the blood are linked to more severe complications. Researchers measured homocysteine using a standard lab test and compared it to how serious each patient's condition was. The goal is to find a simple way to identify which patients need closer monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ain shams University
Cairo, Cairo Governorate, 11591, Egypt
-
Ain shams university
Cairo, Cairo Governorate, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If homocysteine levels reliably indicate preeclampsia severity, doctors could use a simple blood test to identify high-risk patients earlier.
What could go wrong
This is a small, completed observational study, not a treatment trial. The results may not apply to all preeclampsia patients, and homocysteine may not be a strong enough marker on its own.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.